ON-DEMAND WEBINAR

R&D in an Age of Multiplying Modalities and Targets

Michael Ward
Global Head of Thought Leadership, Life Sciences and Healthcare
Clarivate
Kenneth Beers
Partner, Consulting
Clarivate

The multiplicative expansion of modalities, targets, and diseases creates many new opportunities but challenges the traditional blockbuster model. We examine the evolution of the R&D landscape and its drivers, as the number and diversity of approaches grow and consider implications for development strategy, clinical trials, and ROI.